(Press-News.org) CAMBRIDGE, MA -- Engineers at MIT and the University of California at San Diego (UCSD) have devised a new way to detect cancer that has spread to the liver, by enlisting help from probiotics -- beneficial bacteria similar to those found in yogurt.
Many types of cancer, including colon and pancreatic, tend to metastasize to the liver. The earlier doctors can find these tumors, the more likely that they can successfully treat them.
"There are interventions, like local surgery or local ablation, that physicians can perform if the spread of disease in the liver is confined, and because the liver can regenerate, these interventions are tolerated. New data are showing that those patients have a higher survival rate, so there's a particular need for detecting early metastasis in the liver," says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Electrical Engineering and Computer Science at MIT.
Using a harmless strain of E. coli that colonizes the liver, the researchers programmed the bacteria to produce a luminescent signal that can be detected with a simple urine test. Bhatia and Jeff Hasty, a professor of bioengineering at UCSD, are the senior authors of a paper describing the new approach this week in the journal Science Translational Medicine. Lead authors are MIT postdoc Tal Danino and UCSD postdoc Arthur Prindle.
Microbial help
Previous studies had shown that bacteria can penetrate and grow in the tumor microenvironment, where there are lots of nutrients and the body's immune system is compromised. Because of this, scientists have been trying for many years to develop bacteria as a possible vehicle for cancer treatment.
The MIT and UCSD researchers began exploring this idea a few years ago, but soon expanded their efforts to include the concept of creating a bacterial diagnostic.
To turn bacteria into diagnostic devices, the researchers engineered the cells to express the gene for a naturally occurring enzyme called lacZ that cleaves lactose into glucose and galactose. In this case, lacZ acts on a molecule injected into the mice, consisting of galactose linked to luciferin, a luminescent protein naturally produced by fireflies. Luciferin is cleaved from galactose and excreted in the urine, where it can easily be detected using a common laboratory test.
At first, the researchers were interested in developing these bacteria for injection into patients, but then decided to investigate the possibility of delivering the bacteria orally, just like the probiotic bacteria found in yogurt. To achieve that, they integrated their diagnostic circuits into a harmless strain of E. coli called Nissle 1917, which is marketed as a promoter of gastrointestinal health.
In tests with mice, the researchers found that orally delivered bacteria do not accumulate in tumors all over the body, but they do predictably zero in on liver tumors because the hepatic portal vein carries them from the digestive tract to the liver.
"We realized that if we gave a probiotic, we weren't going to be able to get bacteria concentrations high enough to colonize the tumors all over the body, but we hypothesized that if we had tumors in the liver they would get the highest dose from an oral delivery," says Bhatia, who is a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science.
This allowed the team to develop a diagnostic specialized for liver tumors. In tests in mice with colon cancer that has spread to the liver, the probiotic bacteria colonized nearly 90 percent of the metastatic tumors.
In the mouse experiments, animals that were given the engineered bacteria did not exhibit any harmful side effects.
More sensitive detection
The researchers focused on the liver not only because it is a natural target for these bacteria, but also because the liver is hard to image with conventional imaging techniques like CT scanning or magnetic resonance imaging (MRI), making it difficult to diagnose metastatic tumors there.
With the new system, the researchers can detect liver tumors larger than about one cubic millimeter, offering more sensitivity than existing imaging methods. This kind of diagnostic could be most useful for monitoring patients after they have had a colon tumor removed because they are at risk for recurrence in the liver, Bhatia says.
The MIT team is now pursuing the idea of using probiotic bacteria to treat cancer, as well as for diagnosing it.
INFORMATION:
The research was funded by the Ludwig Center for Molecular Oncology at MIT, a Prof. Amar G. Bose Research Grant, the National Institutes of Health through the San Diego Center for Systems Biology, and the Koch Institute Support Grant from the National Cancer Institute.
Given the aging of the population and the low birthrate both in Japan and elsewhere, healthcare professionals are in short supply and unevenly distributed, giving rise to a need for alternatives to humans for performing simple tasks. Although increasing numbers of medical institutions have introduced electronic medical records, a variety of issues remain unresolved, such as the inconvenience of data recording and the high costs associated with data input.
The use of robots to support medical care data management and the delivery of resources at the medical front--thus ...
A breakthrough in machine learning has also brought about a "game changer" for the science of metabolomics - and will hasten the development of diagnostic and predictive tests for Alzheimer's, cancer, diabetes and numerous other conditions, leading to improved prevention and treatment.
University of Alberta computing science PhD graduate Siamak Ravanbakhsh published his research in the scientific journal PLOS ONE on an automated process that increases the speed and accuracy of producing a person's metabolic profile from a sample of biofluid such as blood serum or cerebrospinal ...
A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count--a key measure of immune system health--is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together with data from previous studies showing that antiretroviral treatment reduced the risk of HIV transmission to uninfected sexual partners, these findings support offering treatment to everyone with HIV.
The ...
(Boston)--Reductions in federal support and clinical revenue not only jeopardize biomedical research at academic medical centers, but may ultimately impact clinical medicine according to an opinion piece in the journal Science Translational Medicine.
Biomedical research is crucial to the US national agenda and academic medical centers--the provenance for much of this research - are at particular risk, according to the authors. Persistent constraints on federal funding threaten to undermine this, and decreasing clinical revenue due to increasingly constrained reimbursement ...
(SACRAMENTO, Calif.) -- Do microbes grow differently on the International Space Station than they do on Earth? Results from the growth of microbes collected by citizen scientists in Project MERCCURI indicate that most behave similarly in both places.
"While this data is extremely preliminary, it is potentially encouraging for long-term manned spaceflight," said David Coil, Ppoject scientist in the microbiology lab of Jonathan Eisen at the University of California, Davis.
"With this part of Project MERCCURI we hoped to shed light on how microbes associated with the normal, ...
From AGU's blogs: Should NASA be Studying the Earth?
Joseph R. Dwyer, a Professor at the Department of Physics and the Space Science Center in the Institute for the Study of Earth, Oceans, and Space at the University of New Hampshire, shares his thoughts about whether NASA should be studying the Earth in a blog post on The Bridge.
From Eos.org: Musical Composition Conveys Climate Change Data
A student at the University of Minnesota communicates climate change science in an innovative way.
From AGU's journals: Dynamics of the Earth's Surface in the Eastern Tibetan ...
When you're blasting though space at more than 98 percent of the speed of light, you may need driver's insurance. Astronomers have discovered for the first time a rear-end collision between two high-speed knots of ejected matter. This discovery was made while piecing together a time-lapse movie of a plasma jet blasted from a supermassive black hole inside a galaxy located 260 million light-years from earth.
The finding offers new insights into the behavior of "light saber-like" jets that are so energized that they appear to zoom out of black hole at speeds several times ...
Cleveland . . . A new relative joins "Lucy" on the human family tree. An international team of scientists, led by Dr. Yohannes Haile-Selassie of The Cleveland Museum of Natural History, has discovered a 3.3 to 3.5 million-year-old new human ancestor species. Upper and lower jaw fossils recovered from the Woranso-Mille area of the Afar region of Ethiopia have been assigned to the new species Australopithecus deyiremeda. This hominin lived alongside the famous "Lucy's" species, Australopithecus afarensis. The species will be described in the May 28, 2015 issue of the international ...
Ovarian cancer cells can lock into survival mode and avoid being destroyed by chemotherapy, an international study reports.
Professor Sean Grimmond, from The University of Queensland's Institute for Molecular Bioscience, said ovarian cancer cells had at least four different ways to avoid being destroyed by platinum-based chemotherapy treatments.
"One way involves breaking and rearranging big groups of genes - the chromosomes," Professor Grimmond said.
"This is fundamentally different to other cancers where the disease is driven by smaller but more gradual changes ...
Is it possible to tap into the signalling in the brain to figure out where you will go next? Hiroshi Ito, a researcher at the Kavli Institute for Systems Neuroscience at the Norwegian University of Science and Technology (NTNU), can now say yes. Ito has just published a description of how this happens in this week's edition of Nature.
Ito and his colleagues, including his supervisors, 2014 Nobel Laureates May-Britt and Edvard Moser, sampled a specific neural pathway to figure out if it is the location of the mechanism that enables animals to code their plan to get from ...
